hVIVO is the new name of Retroscreen Virology! (from 15 April 2015).
hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
Tuesday, 24 July 2012
NanoViricides Retains a Consulting Firm to Expedite First FluCide(TM) Human Trials in Australia - MarketWatch
No comments:
Post a Comment